These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 17449413

  • 41. Should UNOS Status 2 patients undergo transplantation?
    Moazami N, Shah NR, Ewald GA, Geltman EM, Moorhead SL, Pasque MK.
    Heart Surg Forum; 2006; 9(6):E823-7. PubMed ID: 16893757
    [Abstract] [Full Text] [Related]

  • 42. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [Abstract] [Full Text] [Related]

  • 43. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW, Healy AH, Rasmusson BY, Cowley CG, Nelson KE, Kfoury AG, Clayson SE, Reid BB, Moore SA, Blank DU, Renlund DG.
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [Abstract] [Full Text] [Related]

  • 44. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy.
    Stevenson LW.
    Circulation; 2003 Jul 29; 108(4):492-7. PubMed ID: 12885733
    [No Abstract] [Full Text] [Related]

  • 45. CardioWest (Jarvik) total artificial heart: a single-center experience with 42 patients.
    Roussel JC, Sénage T, Baron O, Périgaud C, Habash O, Rigal JC, Treilhaud M, Trochu JN, Despins P, Duveau D.
    Ann Thorac Surg; 2009 Jan 29; 87(1):124-9; discussion 130. PubMed ID: 19101284
    [Abstract] [Full Text] [Related]

  • 46. Extra-corporeal life support following cardiac surgery in children: analysis of risk factors and survival in a single institution.
    Alsoufi B, Al-Radi OO, Gruenwald C, Lean L, Williams WG, McCrindle BW, Caldarone CA, Van Arsdell GS.
    Eur J Cardiothorac Surg; 2009 Jun 29; 35(6):1004-11; discussion 1011. PubMed ID: 19356943
    [Abstract] [Full Text] [Related]

  • 47. Dobutamine-related asthma in a patient awaiting cardiac transplantation: the eosinophilic dilemma.
    Aranda JM, Woo G, Pauly DF, Rodriguez E, Hill JA, Schofield RS.
    J Heart Lung Transplant; 2004 Feb 29; 23(2):260-1. PubMed ID: 14761776
    [Abstract] [Full Text] [Related]

  • 48. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW.
    Circulation; 2007 Jul 31; 116(5):497-505. PubMed ID: 17638928
    [Abstract] [Full Text] [Related]

  • 49. Long-term intravenous inotropes in low-output terminal heart failure?
    von Scheidt W, Pauschinger M, Ertl G.
    Clin Res Cardiol; 2016 Jun 31; 105(6):471-81. PubMed ID: 26879807
    [Abstract] [Full Text] [Related]

  • 50. Place of death among patients with terminal heart failure in a continuous inotropic infusion program.
    Taitel M, Meaux N, Pegus C, Valerian C, Kirkham H.
    Am J Hosp Palliat Care; 2012 Jun 31; 29(4):249-53. PubMed ID: 21840872
    [Abstract] [Full Text] [Related]

  • 51. Long-term (> 8 weeks) home inotropic therapy as destination therapy in patients with advanced heart failure or as bridge to heart transplantation.
    Jiménez J, Jara J, Bednar B, Bauerlein J, Mallon S.
    Int J Cardiol; 2005 Mar 10; 99(1):47-50. PubMed ID: 15721498
    [No Abstract] [Full Text] [Related]

  • 52. Cardiac resynchronization therapy: long-term alternative to cardiac transplantation?
    Hansky B, Vogt J, Zittermann A, Güldner H, Heintze J, Schulz U, Horstkotte D, Tenderich G, Körfer R.
    Ann Thorac Surg; 2009 Feb 10; 87(2):432-8. PubMed ID: 19161754
    [Abstract] [Full Text] [Related]

  • 53. Costs associated with ventricular assist device use in children.
    Mahle WT, Ianucci G, Vincent RN, Kanter KR.
    Ann Thorac Surg; 2008 Nov 10; 86(5):1592-7. PubMed ID: 19049755
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Milrinone for long-term pharmacologic support of the status 1 heart transplant candidates.
    Canver CC, Chanda J.
    Ann Thorac Surg; 2000 Jun 10; 69(6):1823-6. PubMed ID: 10892930
    [Abstract] [Full Text] [Related]

  • 56. Inotropic therapy for heart failure: an evidence-based approach.
    Felker GM, O'Connor CM.
    Am Heart J; 2001 Sep 10; 142(3):393-401. PubMed ID: 11526351
    [Abstract] [Full Text] [Related]

  • 57. Continuous milrinone infusion during preoperative anti-inflammatory therapy in inflammatory aortic aneurysm complicating severe congestive heart failure.
    Takeno M, Takagi S, Sakuragi S, Suzuki S, Tsutsumi Y, Nonogi H, Goto Y.
    Heart Vessels; 2002 Nov 10; 17(1):42-4. PubMed ID: 12434201
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Comparative costs of home positive inotropic infusion versus in-hospital care in patients awaiting cardiac transplantation.
    Upadya SP, Sedrakyan A, Saldarriaga C, Nystrom K, Bozzo J, Lee FA, Katz SD.
    J Card Fail; 2004 Oct 10; 10(5):384-9. PubMed ID: 15470648
    [Abstract] [Full Text] [Related]

  • 60. Parenteral inotropic support for advanced congestive heart failure.
    Leier CV, Binkley PF.
    Prog Cardiovasc Dis; 1998 Oct 10; 41(3):207-24. PubMed ID: 9872607
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.